Innovative Cardiac Solutions Genetesis specializes in advanced biomagnetic imaging technology for cardiovascular health, offering a unique platform that could be integrated into hospitals and clinics aiming to enhance preventive cardiac care and early diagnosis.

Growing Market Presence The recent expansion of partnerships, including the City of Mason, and the launch of the CardioFlux Membership program indicate increasing adoption and market interest, presenting opportunities to target healthcare providers seeking innovative cardiac solutions.

Strong Financial Backing With recent $17.5M Series C funding and a total funding of $18M, Genetesis is well-resourced to expand its product offerings and sales channels, making it a viable partner for strategic collaborations and technology integrations.

Technological Edge Genetesis employs a robust tech stack including cloud-based services and data science tools, positioning it to appeal to technologically advanced healthcare institutions seeking data-driven diagnostic capabilities.

Leadership & Expertise The addition of a Chief Medical Officer and strategic clinical initiatives suggest a focus on clinical validation and partnership building, offering avenues to engage key decision-makers involved in cardiovascular health and innovation.